skip to navigation skip to content

Business Weekly: New £25m China investment for Cambridge life sciences lined up via Cambridge Judge and AZ


China Medical System, a pharmaceutical company listed on the Hong Kong Stock Exchange, has signalled its confidence in the UK biotech and life sciences sectors through intended investment of up to £25 million in early stage UK biotech and life sciences businesses, with support from AstraZeneca and Cambridge Judge Business School.

Read the full article []